4.7 Article Proceedings Paper

Analytical evaluation of a rapid on-site oral fluid drug test

Journal

ANALYTICAL AND BIOANALYTICAL CHEMISTRY
Volume 396, Issue 7, Pages 2461-2468

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00216-010-3463-8

Keywords

Saliva; Point-of-care test; Varian Oralab (R) 6; Sensitivity

Ask authors/readers for more resources

There is a need for a reliable rapid on-site oral fluid test that can be used in police controls to detect impaired drivers. We evaluated the Varian OralabA (R) 6 and collected two oral fluid samples from 250 subjects, one with the Varian OralabA (R) 6 and one with the StatSure (TM) SalivaaEuro cent Sampler (TM). The OralabA (R) 6 can detect six drug types: amphetamines, methamphetamine, cocaine, opiates, delta9-tetrahydrocannabinol (THC), and phencyclidine (PCP). On-site results were obtained within 10 to 15 min. The sample collected with StatSure (TM) was analyzed using liquid chromatography-tandem mass spectrometry after liquid-liquid extraction and these results were used as a reference to determine prevalence, sensitivity, and specificity. Two cut-off values were used in the evaluation. The Varian cut-off values were: amphetamine 50 ng/mL, cocaine 20 ng/mL, opiates 40 ng/mL, and THC 50 ng/mL. The DRUID cut-offs were: amphetamine 25 ng/mL, cocaine 20 ng/mL, opiates 20 ng/mL, and THC 1 ng/mL. Applying the first cut-offs, prevalence, sensitivity, and specificity were: amphetamine 10%, 76%, 100%; cocaine 23%, 34%, 100%; opiates 38%, 83%, 94%; and THC 18%, 41%, 99%. The DRUID cut-off values gave the following results: amphetamine 14%, 56%, 100%; cocaine 28%, 34%, 100%; opiates 49%, 68%, 98%, and THC 45%, 16%, 99%. The specificity of the OralabA (R) 6 is generally good. For both cut-offs, sensitivity was low for cocaine and THC. Therefore, the Varian OralabA (R) 6 test is not sensitive enough to be applied during roadside police controls.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Medical Laboratory Technology

Reformulated Architect (R) cyclosporine CMIA assay: improved imprecision, worse comparability between methods

Nick Verougstraete, Alain G. Verstraete, Veronique Stove, Matthijs Oyaert

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Medicine, General & Internal

Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur)

Veerle Casneuf, Ivan Borbath, Marc van den Eynde, Yolanda Verheezen, Wim Demey, Alain G. Verstraete, Kathleen Bm Claes, Vincent Haufroid, Karen P. Geboes

Summary: Fluoropyrimidines are commonly used in the treatment of malignancies, but genetic variations within the DPYD gene can lead to reduced DPD activity, causing potential toxicity. In Belgium, screening for DPD deficiency before starting treatment with fluoropyrimidines is recommended, with a preference for phenotype testing due to higher sensitivity and lower cost to society.

ACTA CLINICA BELGICA (2022)

Article Medicine, General & Internal

Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care

Viviane Van Hoof, Dragos Barglazan, Laurent Blairon, Bob Braekevelt, Regis Debois, Nathalie Veronique J. De Vos, Damien Gruson, Jef Jonckheere, Katrien Lanckmans, Marc Moens, Bart Peeters, Joris Penders, Alain Roman, Lieve Van Hoovels, Florent Vanstapel, Jan Y. Verbakel, Ann Verdonck, Alain G. Verstraete

Summary: There is a lack of legal framework for the use of POCT outside hospitals. It is proposed that tests should be carried out within a legal framework and in collaboration with clinical laboratories to ensure quality and accuracy. Government investment can be offset by health benefits.

ACTA CLINICA BELGICA (2022)

Article Biochemical Research Methods

A sensitive and high-throughput quantitative liquid chromatography high-resolution mass spectrometry method for therapeutic drug monitoring of 10 β-lactam antibiotics, linezolid and two β-lactamase inhibitors in human plasma

Sarah Van Vooren, Alain G. Verstraete

Summary: An UHPLC-HRMS method was developed for simultaneous and sensitive quantification of 10 beta-lactam antibiotics, linezolid, and beta-lactamase inhibitors in human plasma. The method showed high sensitivity and accuracy, allowing it to be suitable for routine therapeutic drug monitoring.

BIOMEDICAL CHROMATOGRAPHY (2021)

Article Clinical Neurology

Long-term chemogenetic suppression of seizures in a multifocal rat model of temporal lobe epilepsy

Marie-Gabrielle Goossens, Paul Boon, Wytse Wadman, Chris Van den Haute, Veerle Baekelandt, Alain G. Verstraete, Kristl Vonck, Lars E. Larsen, Mathieu Sprengers, Evelien Carrette, Jana Desloovere, Alfred Meurs, Jean Delbeke, Christian Vanhove, Robrecht Raedt

Summary: This study demonstrates potent seizure-suppressing effects in the intraperitoneal kainic acid rat model by chemogenetically inhibiting the hippocampus, even 1 year after viral transduction. Despite the need for further optimization, chemogenetic neuromodulation represents a promising treatment prospect for temporal lobe epilepsy.

EPILEPSIA (2021)

Article Medical Laboratory Technology

Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry Analyzers

Nick Verougstraete, Veronique Stove, Alain G. Verstraete, Matthijs Oyaert

Summary: This study evaluated the performance of a new nanoparticle-based competitive immunoassay on two routine clinical chemistry analyzers and compared it to high-resolution mass spectrometry. The results showed that the immunoassay had good analytical performance and high agreement with the mass spectrometry results.

THERAPEUTIC DRUG MONITORING (2022)

Article Toxicology

First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass

Marthe M. Vandeputte, Nick Verougstraete, Donna Walther, Grant C. Glatfelter, Jeroen Malfliet, Michael H. Baumann, Alain G. Verstraete, Christophe P. Stove

Summary: This study provides a detailed chemical analysis and pharmacological characterization of N-Piperidinyl etonitazene. The results indicate that N-Piperidinyl etonitazene is a potent opioid with the potential to cause harm in users.

ARCHIVES OF TOXICOLOGY (2022)

Article Critical Care Medicine

Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome*

Tatjana Van der Heggen, Evelyn Dhont, Jef Willems, Ingrid Herck, Joris R. Delanghe, Veronique Stove, Alain G. Verstraete, Sophie Vanhaesebrouck, Peter De Paepe, Pieter A. J. G. De Cock

Summary: This study aimed to investigate the target attainment of beta-lactam antibiotics in critically ill children, identify risk factors for suboptimal exposure, and examine the association between target nonattainment and clinical outcome.

PEDIATRIC CRITICAL CARE MEDICINE (2022)

Review Oncology

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples

Nick Verougstraete, Veronique Stove, Alain G. Verstraete, Christophe P. Stove

Summary: Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKIs) is not yet performed routinely in oncology patients, but it has the potential to improve treatment outcomes and minimize toxicity. This review focuses on the use of dried blood microsamples for quantifying TKIs, discussing various methodological aspects and challenges associated with quantitative analyses. The use of dried blood microsamples offers convenience, cost-effectiveness, and improved compound stability.

FRONTIERS IN ONCOLOGY (2022)

Article Medical Laboratory Technology

Analytical performance of eight enzymatic assays for ethanol in serum evaluated by data from the Belgian external quality assessment scheme

Wim Coucke, Corinne Charlier, Kathleen Croes, Boris Mahieu, Hugo Neels, Christophe Stove, Jan Tytgat, Andre Vanescote, Alain G. Verstraete, Sarah Wille, Arnaud Capron

Summary: This study evaluates the performance of automated systems in ethanol concentration analysis. The results show that Alinity c performs poorly in terms of bias and measurement uncertainty, while Architect and Cobas c501/c502 systems have the lowest variability.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2022)

Article Medical Informatics

Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients

Jarne Verhaeghe, Sofie A. M. Dhaese, Thomas De Corte, David Vander Mijnsbrugge, Heleen Aardema, Jan G. Zijlstra, Alain G. Verstraete, Veronique Stove, Pieter Colin, Femke Ongenae, Jan J. De Waele, Sofie Van Hoecke

Summary: This study developed machine learning models for predicting piperacillin plasma concentrations and providing uncertainty quantification. The results showed that these models can accurately estimate piperacillin concentrations and provide useful uncertainty predictions when the same dosing regimens are used. However, their generalization capabilities to other dosing schemes are limited.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2022)

Article Biochemical Research Methods

Identification of etazene (etodesnitazene) metabolites in human urine by LC-HRMS

Nick Verougstraete, Annick Verhaeghe, Jan Germonpre, Herve Lebbinck, Alain G. Verstraete

Summary: Etazene is a novel synthetic opioid that has been detected through analysis of urine samples. Its metabolites can be used to determine exposure to Etazene.

DRUG TESTING AND ANALYSIS (2023)

Letter Infectious Diseases

Pretomanid-resistant tuberculosis

Niklas Koehler, Soenke Andres, Matthias Merker, Viola Dreyer, Agnieszka John, Martin Kuhns, David Krieger, Eva Choong, Nick Verougstraete, Pia Abel zur Wiesch, Sebastian G. Wicha, Christina Koenig, Barbara Kalsdorf, Patricia M. Sanchez Carballo, Dagmar Schaub, Jim Werngren, Thomas Schon, Charles A. Peloquin, Nicolas Schoenfeld, Alain G. Verstraete, Laurent A. Decosterd, Rob Aarnoutse, Stefan Niemann, Florian P. Maurer, Christoph Lange

JOURNAL OF INFECTION (2023)

Article Critical Care Medicine

Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study

Thomas De Corte, Jarne Verhaeghe, Sofie Dhaese, Sarah Van Vooren, Jerina Boelens, Alain G. Verstraete, Veronique Stove, Femke Ongenae, Liesbet De Bus, Pieter Depuydt, Sofie Van Hoecke, Jan J. De Waele

Summary: This study evaluated the pathogen-based clinically relevant target attainment of piperacillin-tazobactam and meropenem in surgical ICU patients. Despite achieving better results in the pathogen-based scenario compared to the worst-case scenario, a substantial proportion of samples did not attain commonly used PK/PD targets.

ANNALS OF INTENSIVE CARE (2023)

Meeting Abstract Respiratory System

Late Breaking Abstract - Therapeutic drug monitoring in a patient with very advanced XDR-TB

Niklas Koehler, Rob Aarnoutse, Pia Abel Zur Wiesch, Sonke Andres, Robert A. Bonomo, Eva Choong, Fabrizio Clarelli, Laurent Decosterd, Andrew Dinardo, Hans-Peter Grobbel, Jan Heyckendorf, Doris Hillemann, Harald Hoffmann, Barbara Kalsdorf, Hande Karakose, Wiebke Knaack, Christina Koenig, Antal Martinecz, Florian Maurer, Matthias Merker, Stefan Niemann, Markus Nowak, Charles A. Peloquin, Patricia Sanchez Carballo, Dagmar Schaub, Thomas Schoen, Dominik Schwudke, Marga Teulen, Nick Verougstraete, Alain Verstraete, Franziska Waldow, Jim Werngren, Sebastian Georg Wicha, Christoph Lange

EUROPEAN RESPIRATORY JOURNAL (2021)

No Data Available